- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.51 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x MVQ: (2~{R})-1-[6-methyl-5-(oxan-4-yl)-7-oxidanylidene-[1,3]thiazolo[5,4-d]pyrimidin-2-yl]-~{N}-(phenylmethyl)pyrrolidine-2-carboxamide(Non-covalent)
- 16 x CD: CADMIUM ION(Non-covalent)
CD.2: 3 residues within 4Å:- Chain A: H.314
- Chain B: C.149, E.153
Ligand excluded by PLIPCD.3: 2 residues within 4Å:- Chain A: D.196, E.242
Ligand excluded by PLIPCD.4: 3 residues within 4Å:- Chain A: E.27, M.28, D.251
Ligand excluded by PLIPCD.5: 2 residues within 4Å:- Chain A: D.347, D.351
Ligand excluded by PLIPCD.6: 1 residues within 4Å:- Chain A: H.375
Ligand excluded by PLIPCD.7: 3 residues within 4Å:- Chain A: L.176, G.180, C.181
Ligand excluded by PLIPCD.8: 1 residues within 4Å:- Chain A: D.137
Ligand excluded by PLIPCD.9: 1 residues within 4Å:- Chain A: E.309
Ligand excluded by PLIPCD.13: 3 residues within 4Å:- Chain A: C.149, E.153
- Chain B: H.314
Ligand excluded by PLIPCD.14: 2 residues within 4Å:- Chain B: D.196, E.242
Ligand excluded by PLIPCD.15: 3 residues within 4Å:- Chain B: E.27, M.28, D.251
Ligand excluded by PLIPCD.16: 2 residues within 4Å:- Chain B: D.347, D.351
Ligand excluded by PLIPCD.17: 1 residues within 4Å:- Chain B: H.375
Ligand excluded by PLIPCD.18: 3 residues within 4Å:- Chain B: L.176, G.180, C.181
Ligand excluded by PLIPCD.19: 1 residues within 4Å:- Chain B: D.137
Ligand excluded by PLIPCD.20: 1 residues within 4Å:- Chain B: E.309
Ligand excluded by PLIP- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x ACT: ACETATE ION(Non-functional Binders)
ACT.11: 9 residues within 4Å:- Chain A: S.62, L.63, A.64, G.65, G.66, L.67
- Chain B: S.428, S.430, S.431
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:G.65, A:L.67, A:L.67
ACT.22: 9 residues within 4Å:- Chain A: S.428, S.430, S.431
- Chain B: S.62, L.63, A.64, G.65, G.66, L.67
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:G.65, B:L.67, B:L.67
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kalliokoski, T. et al., Discovery of sulfonamides and 9-oxo-2,8-diazaspiro[5,5]undecane-2-carboxamides as human kynurenine aminotransferase 2 (KAT2) inhibitors. Bioorg.Med.Chem.Lett. (2020)
- Release Date
- 2020-03-04
- Peptides
- Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.51 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x MVQ: (2~{R})-1-[6-methyl-5-(oxan-4-yl)-7-oxidanylidene-[1,3]thiazolo[5,4-d]pyrimidin-2-yl]-~{N}-(phenylmethyl)pyrrolidine-2-carboxamide(Non-covalent)
- 16 x CD: CADMIUM ION(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x ACT: ACETATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kalliokoski, T. et al., Discovery of sulfonamides and 9-oxo-2,8-diazaspiro[5,5]undecane-2-carboxamides as human kynurenine aminotransferase 2 (KAT2) inhibitors. Bioorg.Med.Chem.Lett. (2020)
- Release Date
- 2020-03-04
- Peptides
- Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A